(Q40868039)

English

ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia

scientific article published on July 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 September 2017

ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia (English)

1 reference

Europe PubMed Central

24 September 2017

cerebral infarction

1 reference

based on heuristic

inferred from title

author name string

O'Neill MJ

1

1 reference

Europe PubMed Central

24 September 2017

Murray TK

2

1 reference

Europe PubMed Central

24 September 2017

McCarty DR

3

1 reference

Europe PubMed Central

24 September 2017

Hicks CA

4

1 reference

Europe PubMed Central

24 September 2017

Dell CP

5

1 reference

Europe PubMed Central

24 September 2017

Patrick KE

6

1 reference

Europe PubMed Central

24 September 2017

Ward MA

7

1 reference

Europe PubMed Central

24 September 2017

Osborne DJ

8

1 reference

Europe PubMed Central

24 September 2017

Wiernicki TR

9

1 reference

Europe PubMed Central

24 September 2017

Roman CR

10

1 reference

Europe PubMed Central

24 September 2017

Lodge D

11

1 reference

Europe PubMed Central

24 September 2017

Fleisch JH

12

1 reference

Europe PubMed Central

24 September 2017

Singh J

13

1 reference

Europe PubMed Central

24 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2000

1 reference

Europe PubMed Central

24 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

24 September 2017

871

1 reference

Europe PubMed Central

24 September 2017

234-244

1 reference

Europe PubMed Central

24 September 2017

2

1 reference

Europe PubMed Central

24 September 2017

Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

NG-Nitro-L-arginine protects against ischaemia-induced increases in nitric oxide and hippocampal neuro-degeneration in the gerbil

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

NG-nitro-L-arginine methyl ester protects against lipid peroxidation in the gerbil following cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Nitric oxide synthases: targets for therapeutic strategies in neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Nitric oxide: foe or friend to the injured brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

A comparative study of the effects of two nitric oxide synthase inhibitors and two nitric oxide donors on temporary focal cerebral ischemia in the Wistar rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Cerebroprotective effect of the nitric oxide synthase inhibitors, 1-(2-trifluoromethylphenyl) imidazole and 7-nitro indazole, after transient focal cerebral ischemia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Nitric oxide: from basic research to clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

The antinociceptive effect of 1-(2-trifluoromethylphenyl) imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Effect of AR-R 17477, a potent neuronal nitric oxide synthase inhibitor, on infarction volume resulting from permanent focal ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Nitric oxide production in the CA1 field of the gerbil hippocampus after transient forebrain ischemia : effects of 7-nitroindazole and NG-nitro-L-arginine methyl ester.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Nitric oxide synthase in cerebral ischemia. Possible contribution of nitric oxide synthase activation in brain microvessels to cerebral ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Regional measurements of NO formed in vivo during brain ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Attenuated hippocampal damage after global cerebral ischemia in mice mutant in neuronal nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester decreases ischemic damage in reversible focal cerebral ischemia in hyperglycemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Endothelin-1 induced middle cerebral artery occlusion: pathological consequences and neuroprotective effects of MK801.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Synergistic protective effects of antioxidant and nitric oxide synthase inhibitor in transient focal ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Consecutive evaluation of nitric oxide production after transient cerebral ischemia in the rat hippocampus using in vivo brain microdialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Oxygen radical mechanisms of brain injury following ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Role of nitric oxide in traumatic brain injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Effects of L-NAME and 7-NI on NOS catalytic activity and behavioral outcome after traumatic brain injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

NG-nitro-L-arginine enhances neuronal death following transient forebrain ischemia in gerbils

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Induction of nitric oxide synthase activity in rodent brain following middle cerebral artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Reversible middle cerebral artery occlusion without craniectomy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902471-9

7 January 2021

Identifiers

10.1016/S0006-8993(00)02471-9

1 reference

Europe PubMed Central

24 September 2017

1 reference

Europe PubMed Central

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40868039&oldid=2070509251"